Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86,559,040
-
Total 13F shares
-
48,482,656
-
Share change
-
+2,071,963
-
Total reported value
-
$1,083,969,550
-
Put/Call ratio
-
71%
-
Price per share
-
$22.36
-
Number of holders
-
130
-
Value change
-
+$46,478,159
-
Number of buys
-
67
-
Number of sells
-
66
Institutional Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q1 2021
As of 31 Mar 2021,
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) was held by
130 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
48,482,656 shares.
The largest 10 holders included
Avidity Partners Management LP, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., STATE STREET CORP, Avoro Capital Advisors LLC, BOXER CAPITAL, LLC, CITADEL ADVISORS LLC, VANGUARD GROUP INC, EVENTIDE ASSET MANAGEMENT, LLC, and Nantahala Capital Management, LLC.
This page lists
130
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.